Table 1 The clinical characteristics of 136 patients with advanced gastric cancer
Characteristic | Total n = 136 (%) | NLR | PLR | ||
|---|---|---|---|---|---|
Mean ± SEM | P value | Mean ± SEM | P value | ||
Gender | Â | Â | 0.876 | Â | 0.115 |
 Male | 82 (60.3%) | 3.36 ± 0.30 |  | 191.66 ± 11.84 |  |
 Female | 54 (39.7%) | 3.43 ± 0.37 |  | 222.64 ± 16.00 |  |
Age | Â | Â | 0.446 | Â | 0.966 |
 ≤55 years | 74 (54.4%) | 3.55 ± 0.37 |  | 204.34 ± 12.45 |  |
 >55 years | 62 (45.6%) | 3.20 ± 0.24 |  | 203.51 ± 15.06 |  |
Differentiation | Â | Â | 0.144 | Â | 0.169 |
 Poor | 90 (66.2%) | 3.59 ± 0.32 |  | 213.43 ± 10.70 |  |
 Moderate/Well | 46 (33.8%) | 2.99 ± 0.25 |  | 185.44 ± 19.07 |  |
Chemotherapy regimen | Â | Â | 0.158 | Â | 0.964 |
 FOLFOX | 40 (29.4%) | 3.77 ± 0.52 |  | 209.31 ± 16.29 |  |
 CapeOX | 26 (19.1%) | 3.94 ± 0.70 |  | 200.37 ± 26.76 |  |
 TP | 21 (15.4%) | 3.58 ± 0.42 |  | 210.15 ± 22.98 |  |
 Others | 49 (36.1%) | 2.71 ± 0.22 |  | 198.85 ± 15.84 |  |